c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
about
c-Src-null mice exhibit defects in normal mammary gland development and ERalpha signalingEndocytic down-regulation of ErbB2 is stimulated by cleavage of its C-terminus.Herceptin: from the bench to the clinic.Relationships between serum HER2 ECD, TIMP-1 and clinical outcomes in Taiwanese breast cancerEpidermal growth factor-induced nuclear factor kappa B activation: A major pathway of cell-cycle progression in estrogen-receptor negative breast cancer cells.An updated review on the efficacy of adjuvant endocrine therapies in hormone receptor-positive early breast cancer.Enhanced internalization of ErbB2 in SK-BR-3 cells with multivalent forms of an artificial ligandHER2/neu, Topoisomerase 2a, Estrogen and Progesterone Receptors: Discordance between Primary Breast Cancer and Metastatic Axillary Lymph Node in Expression and Amplification Characteristics.Induction of G2M Arrest by Flavokawain A, a Kava Chalcone, Increases the Responsiveness of HER2-Overexpressing Breast Cancer Cells to Herceptin.Impact of polysomy 17 on HER-2/neu immunohistochemistry in breast carcinomas without HER-2/neu gene amplification.
P2860
Q28504741-2D2C5921-6056-42B3-BD6A-D7B5CE1AEB4CQ30479942-C87F5237-DC9C-4140-B6FB-97A41F5D891AQ34211018-714C12E3-9658-4E6C-BD79-009A13EDF186Q35854297-79BB4492-182C-48A2-B8AA-B59DF9A57532Q37232505-A94539BB-EADF-4898-A552-A98D9DAE981BQ37292419-478F99EF-76B4-4BC1-B360-DEA50F7052F6Q37294882-AE008AA9-C0D5-4085-A28F-23F30EDAFED7Q37677735-16957B4F-0FD7-4A2A-8837-B07325237DE6Q38710973-A9E632C0-2B7F-4E16-9281-0294F7C72F8BQ41955766-90732AFA-B89E-4F67-B811-49C66280DD1D
P2860
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
description
1998 nî lūn-bûn
@nan
1998 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@ast
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@en
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@nl
type
label
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@ast
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@en
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@nl
prefLabel
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@ast
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@en
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@nl
P2093
P2860
P356
P1476
c-erbB2 expression predicts tamoxifen efficacy in breast cancer patients.
@en
P2093
Carlomagno C
De Laurentiis M
De Placido S
P2860
P2888
P356
10.1023/A:1006159001039
P407
P577
1998-01-01T00:00:00Z
P6179
1052898044